NCT05991752View on ClinicalTrials.gov

Health-Economic Evaluation of Early Diagnosis of Epithalial Ovarian Cancer Recurrence Using the ROMA Score: a Prospective Multicenter Randomized Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Epithelial Ovarian Cancer
Interventions
DIAGNOSTIC_TEST

ROMA score evaluation

Every 4 months, for 3 years, patients in the experimental group will done a biological examination based on assessment of the ROMA score (CA125+HE4 assay).

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT05991752 - Health-Economic Evaluation of Early Diagnosis of Epithalial Ovarian Cancer Recurrence Using the ROMA Score: a Prospective Multicenter Randomized Trial | Biotech Hunter | Biotech Hunter